Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
   J01 ANTIBACTERIALS FOR SYSTEMIC USE
   J02 ANTIMYCOTICS FOR SYSTEMIC USE
   J04 ANTIMYCOBACTERIALS
   J05 ANTIVIRALS FOR SYSTEMIC USE
     J05A DIRECT ACTING ANTIVIRALS
       J05AA Thiosemicarbazones
       J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors [DG:DG02840]
       J05AC Cyclic amines
       J05AD Phosphonic acid derivatives
       J05AE Protease inhibitors [DG:DG01647]
         J05AE01 Saquinavir [DG:DG00653]
         J05AE02 Indinavir [DG:DG00654]
         J05AE03 Ritonavir
         J05AE04 Nelfinavir [DG:DG00655]
         J05AE05 Amprenavir
         J05AE07 Fosamprenavir [DG:DG00656]
         J05AE08 Atazanavir [DG:DG00657]
           D07471  Atazanavir (INN)
           D01276  Atazanavir sulfate (JAN/USAN) <JP/US>
         J05AE09 Tipranavir [DG:DG00658]
         J05AE10 Darunavir [DG:DG00659]
       J05AF Nucleoside and nucleotide reverse transcriptase inhibitors [DG:DG01890]
       J05AG Non-nucleoside reverse transcriptase inhibitors [DG:DG01889]
       J05AH Neuraminidase inhibitors [DG:DG02842]
       J05AP Antivirals for treatment of HCV infections
       J05AR Antivirals for treatment of HIV infections, combinations
       J05AX Other antivirals
   J06 IMMUNE SERA AND IMMUNOGLOBULINS
   J07 VACCINES
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: December 6, 2019
According to WHO's ATC 2020

» Japanese version